OrthoAccel Technologies
closedAcceleDent is a hands-free, FDA-cleared, Class II medical device that speeds up orthodontic treatment by as much as 50%.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD82—123m (Dealroom.co estimates Jan 2017.)
Town of Ossining New York (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Seed | |
$360k | Series A | ||
$400k | Series A | ||
$1.3m | Early VC | ||
N/A | $75.0k | Seed | |
N/A | $5.1m | Series A | |
N/A | $1.6m | Early VC | |
N/A | Growth Equity VC | ||
N/A | $12.5m | Series B | |
$5.0m | Series B | ||
$5.0m | Early VC | ||
N/A | $5.0m | Early VC | |
N/A | $12.0m | Series C | |
$15.0m | Series C | ||
$20.5m | Series C | ||
Total Funding | CAD114m |
Related Content
Recent News about OrthoAccel Technologies
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.